nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—Pancytopenia—Ifosfamide—germ cell cancer	0.00574	0.00574	CcSEcCtD
Doxylamine—Dehydration—Cisplatin—germ cell cancer	0.00561	0.00561	CcSEcCtD
Doxylamine—Orthostatic hypotension—Cisplatin—germ cell cancer	0.00551	0.00551	CcSEcCtD
Doxylamine—Agranulocytosis—Dactinomycin—germ cell cancer	0.00549	0.00549	CcSEcCtD
Doxylamine—Breast disorder—Cisplatin—germ cell cancer	0.00545	0.00545	CcSEcCtD
Doxylamine—Cramp muscle—Cisplatin—germ cell cancer	0.00543	0.00543	CcSEcCtD
Doxylamine—Ill-defined disorder—Vinblastine—germ cell cancer	0.00542	0.00542	CcSEcCtD
Doxylamine—Nasopharyngitis—Cisplatin—germ cell cancer	0.00539	0.00539	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Ifosfamide—germ cell cancer	0.00535	0.00535	CcSEcCtD
Doxylamine—Hepatitis—Dactinomycin—germ cell cancer	0.00528	0.00528	CcSEcCtD
Doxylamine—Malaise—Vinblastine—germ cell cancer	0.00526	0.00526	CcSEcCtD
Doxylamine—Flushing—Bleomycin—germ cell cancer	0.00526	0.00526	CcSEcCtD
Doxylamine—Vertigo—Vinblastine—germ cell cancer	0.00525	0.00525	CcSEcCtD
Doxylamine—Leukopenia—Vinblastine—germ cell cancer	0.00523	0.00523	CcSEcCtD
Doxylamine—Pancreatitis—Cisplatin—germ cell cancer	0.00511	0.00511	CcSEcCtD
Doxylamine—Sweating increased—Cisplatin—germ cell cancer	0.00508	0.00508	CcSEcCtD
Doxylamine—Convulsion—Vinblastine—germ cell cancer	0.00506	0.00506	CcSEcCtD
Doxylamine—Bone disorder—Methotrexate—germ cell cancer	0.00505	0.00505	CcSEcCtD
Doxylamine—Agranulocytosis—Ifosfamide—germ cell cancer	0.00503	0.00503	CcSEcCtD
Doxylamine—Abdominal discomfort—Cisplatin—germ cell cancer	0.005	0.005	CcSEcCtD
Doxylamine—Erythema multiforme—Dactinomycin—germ cell cancer	0.00499	0.00499	CcSEcCtD
Doxylamine—Cramp muscle—Etoposide—germ cell cancer	0.00498	0.00498	CcSEcCtD
Doxylamine—Toxic epidermal necrolysis—Etoposide—germ cell cancer	0.00498	0.00498	CcSEcCtD
Doxylamine—Pancytopenia—Cisplatin—germ cell cancer	0.00495	0.00495	CcSEcCtD
Doxylamine—Erythema—Bleomycin—germ cell cancer	0.00493	0.00493	CcSEcCtD
Doxylamine—Bradycardia—Ifosfamide—germ cell cancer	0.00493	0.00493	CcSEcCtD
Doxylamine—Discomfort—Vinblastine—germ cell cancer	0.00491	0.00491	CcSEcCtD
Doxylamine—Flushing—Dactinomycin—germ cell cancer	0.0049	0.0049	CcSEcCtD
Doxylamine—Hepatitis—Ifosfamide—germ cell cancer	0.00484	0.00484	CcSEcCtD
Doxylamine—Hallucination—Ifosfamide—germ cell cancer	0.00482	0.00482	CcSEcCtD
Doxylamine—Urinary tract disorder—Ifosfamide—germ cell cancer	0.00478	0.00478	CcSEcCtD
Doxylamine—Urethral disorder—Ifosfamide—germ cell cancer	0.00475	0.00475	CcSEcCtD
Doxylamine—Bronchospasm—Etoposide—germ cell cancer	0.0047	0.0047	CcSEcCtD
Doxylamine—Thrombocytopenia—Vinblastine—germ cell cancer	0.00467	0.00467	CcSEcCtD
Doxylamine—Sweating increased—Etoposide—germ cell cancer	0.00465	0.00465	CcSEcCtD
Doxylamine—Erythema—Dactinomycin—germ cell cancer	0.0046	0.0046	CcSEcCtD
Doxylamine—Erythema multiforme—Ifosfamide—germ cell cancer	0.00458	0.00458	CcSEcCtD
Doxylamine—Ill-defined disorder—Bleomycin—germ cell cancer	0.00457	0.00457	CcSEcCtD
Doxylamine—Anorexia—Vinblastine—germ cell cancer	0.00454	0.00454	CcSEcCtD
Doxylamine—Pancytopenia—Etoposide—germ cell cancer	0.00454	0.00454	CcSEcCtD
Doxylamine—Eye disorder—Ifosfamide—germ cell cancer	0.00452	0.00452	CcSEcCtD
Doxylamine—Cardiac disorder—Ifosfamide—germ cell cancer	0.00449	0.00449	CcSEcCtD
Doxylamine—Flushing—Ifosfamide—germ cell cancer	0.00449	0.00449	CcSEcCtD
Doxylamine—Malaise—Bleomycin—germ cell cancer	0.00445	0.00445	CcSEcCtD
Doxylamine—Leukopenia—Bleomycin—germ cell cancer	0.00441	0.00441	CcSEcCtD
Doxylamine—Immune system disorder—Ifosfamide—germ cell cancer	0.00437	0.00437	CcSEcCtD
Doxylamine—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00436	0.00436	CcSEcCtD
Doxylamine—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00427	0.00427	CcSEcCtD
Doxylamine—Bradycardia—Cisplatin—germ cell cancer	0.00425	0.00425	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.00422	0.00422	CcSEcCtD
Doxylamine—Erythema—Ifosfamide—germ cell cancer	0.00421	0.00421	CcSEcCtD
Doxylamine—Discomfort—Bleomycin—germ cell cancer	0.00415	0.00415	CcSEcCtD
Doxylamine—Malaise—Dactinomycin—germ cell cancer	0.00415	0.00415	CcSEcCtD
Doxylamine—Decreased appetite—Vinblastine—germ cell cancer	0.00414	0.00414	CcSEcCtD
Doxylamine—Urinary tract disorder—Cisplatin—germ cell cancer	0.00412	0.00412	CcSEcCtD
Doxylamine—Leukopenia—Dactinomycin—germ cell cancer	0.00412	0.00412	CcSEcCtD
Doxylamine—Urethral disorder—Cisplatin—germ cell cancer	0.00409	0.00409	CcSEcCtD
Doxylamine—Constipation—Vinblastine—germ cell cancer	0.00407	0.00407	CcSEcCtD
Doxylamine—Confusional state—Bleomycin—germ cell cancer	0.00406	0.00406	CcSEcCtD
Doxylamine—Anaphylactic shock—Bleomycin—germ cell cancer	0.00402	0.00402	CcSEcCtD
Doxylamine—Agranulocytosis—Etoposide—germ cell cancer	0.00397	0.00397	CcSEcCtD
Doxylamine—Thrombocytopenia—Bleomycin—germ cell cancer	0.00394	0.00394	CcSEcCtD
Doxylamine—Feeling abnormal—Vinblastine—germ cell cancer	0.00393	0.00393	CcSEcCtD
Doxylamine—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00391	0.00391	CcSEcCtD
Doxylamine—Eye disorder—Cisplatin—germ cell cancer	0.0039	0.0039	CcSEcCtD
Doxylamine—Flushing—Cisplatin—germ cell cancer	0.00387	0.00387	CcSEcCtD
Doxylamine—Cardiac disorder—Cisplatin—germ cell cancer	0.00387	0.00387	CcSEcCtD
Doxylamine—Agitation—Ifosfamide—germ cell cancer	0.00387	0.00387	CcSEcCtD
Doxylamine—Discomfort—Dactinomycin—germ cell cancer	0.00387	0.00387	CcSEcCtD
Doxylamine—Angioedema—Ifosfamide—germ cell cancer	0.00385	0.00385	CcSEcCtD
Doxylamine—Anorexia—Bleomycin—germ cell cancer	0.00384	0.00384	CcSEcCtD
Doxylamine—Malaise—Ifosfamide—germ cell cancer	0.0038	0.0038	CcSEcCtD
Doxylamine—Vertigo—Ifosfamide—germ cell cancer	0.00379	0.00379	CcSEcCtD
Doxylamine—Urinary tract disorder—Etoposide—germ cell cancer	0.00378	0.00378	CcSEcCtD
Doxylamine—Leukopenia—Ifosfamide—germ cell cancer	0.00377	0.00377	CcSEcCtD
Doxylamine—Polyuria—Methotrexate—germ cell cancer	0.00377	0.00377	CcSEcCtD
Doxylamine—Immune system disorder—Cisplatin—germ cell cancer	0.00377	0.00377	CcSEcCtD
Doxylamine—Mediastinal disorder—Cisplatin—germ cell cancer	0.00376	0.00376	CcSEcCtD
Doxylamine—Hypotension—Bleomycin—germ cell cancer	0.00376	0.00376	CcSEcCtD
Doxylamine—Urethral disorder—Etoposide—germ cell cancer	0.00375	0.00375	CcSEcCtD
Doxylamine—Palpitations—Ifosfamide—germ cell cancer	0.00372	0.00372	CcSEcCtD
Doxylamine—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00367	0.00367	CcSEcCtD
Doxylamine—Convulsion—Ifosfamide—germ cell cancer	0.00365	0.00365	CcSEcCtD
Doxylamine—Erythema—Cisplatin—germ cell cancer	0.00363	0.00363	CcSEcCtD
Doxylamine—Erythema multiforme—Etoposide—germ cell cancer	0.00361	0.00361	CcSEcCtD
Doxylamine—Dyspnoea—Bleomycin—germ cell cancer	0.00359	0.00359	CcSEcCtD
Doxylamine—Anorexia—Dactinomycin—germ cell cancer	0.00358	0.00358	CcSEcCtD
Doxylamine—Eye disorder—Etoposide—germ cell cancer	0.00357	0.00357	CcSEcCtD
Doxylamine—Cardiac disorder—Etoposide—germ cell cancer	0.00355	0.00355	CcSEcCtD
Doxylamine—Flushing—Etoposide—germ cell cancer	0.00355	0.00355	CcSEcCtD
Doxylamine—Discomfort—Ifosfamide—germ cell cancer	0.00354	0.00354	CcSEcCtD
Doxylamine—Hypersensitivity—Vinblastine—germ cell cancer	0.00351	0.00351	CcSEcCtD
Doxylamine—Decreased appetite—Bleomycin—germ cell cancer	0.0035	0.0035	CcSEcCtD
Doxylamine—Muscle spasms—Cisplatin—germ cell cancer	0.00349	0.00349	CcSEcCtD
Doxylamine—Confusional state—Ifosfamide—germ cell cancer	0.00347	0.00347	CcSEcCtD
Doxylamine—Immune system disorder—Etoposide—germ cell cancer	0.00345	0.00345	CcSEcCtD
Doxylamine—Mediastinal disorder—Etoposide—germ cell cancer	0.00345	0.00345	CcSEcCtD
Doxylamine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00344	0.00344	CcSEcCtD
Doxylamine—Asthenia—Vinblastine—germ cell cancer	0.00342	0.00342	CcSEcCtD
Doxylamine—Tremor—Cisplatin—germ cell cancer	0.0034	0.0034	CcSEcCtD
Doxylamine—Nervous system disorder—Ifosfamide—germ cell cancer	0.00337	0.00337	CcSEcCtD
Doxylamine—Ill-defined disorder—Cisplatin—germ cell cancer	0.00337	0.00337	CcSEcCtD
Doxylamine—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00337	0.00337	CcSEcCtD
Doxylamine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00332	0.00332	CcSEcCtD
Doxylamine—Feeling abnormal—Bleomycin—germ cell cancer	0.00332	0.00332	CcSEcCtD
Doxylamine—Anorexia—Ifosfamide—germ cell cancer	0.00328	0.00328	CcSEcCtD
Doxylamine—Malaise—Cisplatin—germ cell cancer	0.00328	0.00328	CcSEcCtD
Doxylamine—Decreased appetite—Dactinomycin—germ cell cancer	0.00326	0.00326	CcSEcCtD
Doxylamine—Diarrhoea—Vinblastine—germ cell cancer	0.00326	0.00326	CcSEcCtD
Doxylamine—Leukopenia—Cisplatin—germ cell cancer	0.00325	0.00325	CcSEcCtD
Doxylamine—Fatigue—Dactinomycin—germ cell cancer	0.00324	0.00324	CcSEcCtD
Doxylamine—Hypotension—Ifosfamide—germ cell cancer	0.00321	0.00321	CcSEcCtD
Doxylamine—Muscle spasms—Etoposide—germ cell cancer	0.0032	0.0032	CcSEcCtD
Doxylamine—Urticaria—Bleomycin—germ cell cancer	0.0032	0.0032	CcSEcCtD
Doxylamine—Irritability—Methotrexate—germ cell cancer	0.00316	0.00316	CcSEcCtD
Doxylamine—Dizziness—Vinblastine—germ cell cancer	0.00315	0.00315	CcSEcCtD
Doxylamine—Convulsion—Cisplatin—germ cell cancer	0.00315	0.00315	CcSEcCtD
Doxylamine—Mood swings—Methotrexate—germ cell cancer	0.00314	0.00314	CcSEcCtD
Doxylamine—Feeling abnormal—Dactinomycin—germ cell cancer	0.00309	0.00309	CcSEcCtD
Doxylamine—Ill-defined disorder—Etoposide—germ cell cancer	0.00309	0.00309	CcSEcCtD
Doxylamine—Anxiety—Cisplatin—germ cell cancer	0.00308	0.00308	CcSEcCtD
Doxylamine—Dyspnoea—Ifosfamide—germ cell cancer	0.00307	0.00307	CcSEcCtD
Doxylamine—Somnolence—Ifosfamide—germ cell cancer	0.00306	0.00306	CcSEcCtD
Doxylamine—Discomfort—Cisplatin—germ cell cancer	0.00306	0.00306	CcSEcCtD
Doxylamine—Vomiting—Vinblastine—germ cell cancer	0.00303	0.00303	CcSEcCtD
Doxylamine—Malaise—Etoposide—germ cell cancer	0.003	0.003	CcSEcCtD
Doxylamine—Breast disorder—Methotrexate—germ cell cancer	0.00299	0.00299	CcSEcCtD
Doxylamine—Vertigo—Etoposide—germ cell cancer	0.00299	0.00299	CcSEcCtD
Doxylamine—Decreased appetite—Ifosfamide—germ cell cancer	0.00299	0.00299	CcSEcCtD
Doxylamine—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.00298	0.00298	CcSEcCtD
Doxylamine—Leukopenia—Etoposide—germ cell cancer	0.00298	0.00298	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00297	0.00297	CcSEcCtD
Doxylamine—Fatigue—Ifosfamide—germ cell cancer	0.00297	0.00297	CcSEcCtD
Doxylamine—Anaphylactic shock—Cisplatin—germ cell cancer	0.00296	0.00296	CcSEcCtD
Doxylamine—Hypersensitivity—Bleomycin—germ cell cancer	0.00296	0.00296	CcSEcCtD
Doxylamine—Constipation—Ifosfamide—germ cell cancer	0.00294	0.00294	CcSEcCtD
Doxylamine—Nervous system disorder—Cisplatin—germ cell cancer	0.00291	0.00291	CcSEcCtD
Doxylamine—Thrombocytopenia—Cisplatin—germ cell cancer	0.0029	0.0029	CcSEcCtD
Doxylamine—Tachycardia—Cisplatin—germ cell cancer	0.00289	0.00289	CcSEcCtD
Doxylamine—Asthenia—Bleomycin—germ cell cancer	0.00289	0.00289	CcSEcCtD
Doxylamine—Convulsion—Etoposide—germ cell cancer	0.00288	0.00288	CcSEcCtD
Doxylamine—Hyperhidrosis—Cisplatin—germ cell cancer	0.00287	0.00287	CcSEcCtD
Doxylamine—Pruritus—Bleomycin—germ cell cancer	0.00285	0.00285	CcSEcCtD
Doxylamine—Feeling abnormal—Ifosfamide—germ cell cancer	0.00283	0.00283	CcSEcCtD
Doxylamine—Nausea—Vinblastine—germ cell cancer	0.00283	0.00283	CcSEcCtD
Doxylamine—Anorexia—Cisplatin—germ cell cancer	0.00283	0.00283	CcSEcCtD
Doxylamine—Pancreatitis—Methotrexate—germ cell cancer	0.00281	0.00281	CcSEcCtD
Doxylamine—Discomfort—Etoposide—germ cell cancer	0.0028	0.0028	CcSEcCtD
Doxylamine—Hypotension—Cisplatin—germ cell cancer	0.00277	0.00277	CcSEcCtD
Doxylamine—Hypersensitivity—Dactinomycin—germ cell cancer	0.00277	0.00277	CcSEcCtD
Doxylamine—Abdominal discomfort—Methotrexate—germ cell cancer	0.00274	0.00274	CcSEcCtD
Doxylamine—Confusional state—Etoposide—germ cell cancer	0.00274	0.00274	CcSEcCtD
Doxylamine—Urticaria—Ifosfamide—germ cell cancer	0.00273	0.00273	CcSEcCtD
Doxylamine—Pancytopenia—Methotrexate—germ cell cancer	0.00272	0.00272	CcSEcCtD
Doxylamine—Anaphylactic shock—Etoposide—germ cell cancer	0.00272	0.00272	CcSEcCtD
Doxylamine—Asthenia—Dactinomycin—germ cell cancer	0.00269	0.00269	CcSEcCtD
Doxylamine—Thrombocytopenia—Etoposide—germ cell cancer	0.00266	0.00266	CcSEcCtD
Doxylamine—Tachycardia—Etoposide—germ cell cancer	0.00265	0.00265	CcSEcCtD
Doxylamine—Dyspnoea—Cisplatin—germ cell cancer	0.00264	0.00264	CcSEcCtD
Doxylamine—Hyperhidrosis—Etoposide—germ cell cancer	0.00263	0.00263	CcSEcCtD
Doxylamine—Anorexia—Etoposide—germ cell cancer	0.00259	0.00259	CcSEcCtD
Doxylamine—Decreased appetite—Cisplatin—germ cell cancer	0.00258	0.00258	CcSEcCtD
Doxylamine—Diarrhoea—Dactinomycin—germ cell cancer	0.00257	0.00257	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00256	0.00256	CcSEcCtD
Doxylamine—Vomiting—Bleomycin—germ cell cancer	0.00256	0.00256	CcSEcCtD
Doxylamine—Drowsiness—Methotrexate—germ cell cancer	0.00255	0.00255	CcSEcCtD
Doxylamine—Depression—Methotrexate—germ cell cancer	0.00254	0.00254	CcSEcCtD
Doxylamine—Hypotension—Etoposide—germ cell cancer	0.00254	0.00254	CcSEcCtD
Doxylamine—Rash—Bleomycin—germ cell cancer	0.00254	0.00254	CcSEcCtD
Doxylamine—Dermatitis—Bleomycin—germ cell cancer	0.00253	0.00253	CcSEcCtD
Doxylamine—Hypersensitivity—Ifosfamide—germ cell cancer	0.00253	0.00253	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.00253	0.00253	CcSEcCtD
Doxylamine—Asthenia—Ifosfamide—germ cell cancer	0.00247	0.00247	CcSEcCtD
Doxylamine—Sweating—Methotrexate—germ cell cancer	0.00245	0.00245	CcSEcCtD
Doxylamine—Feeling abnormal—Cisplatin—germ cell cancer	0.00244	0.00244	CcSEcCtD
Doxylamine—Pruritus—Ifosfamide—germ cell cancer	0.00243	0.00243	CcSEcCtD
Doxylamine—Dyspnoea—Etoposide—germ cell cancer	0.00242	0.00242	CcSEcCtD
Doxylamine—Somnolence—Etoposide—germ cell cancer	0.00241	0.00241	CcSEcCtD
Doxylamine—Nausea—Bleomycin—germ cell cancer	0.00239	0.00239	CcSEcCtD
Doxylamine—Vomiting—Dactinomycin—germ cell cancer	0.00239	0.00239	CcSEcCtD
Doxylamine—Agranulocytosis—Methotrexate—germ cell cancer	0.00238	0.00238	CcSEcCtD
Doxylamine—Rash—Dactinomycin—germ cell cancer	0.00237	0.00237	CcSEcCtD
Doxylamine—Decreased appetite—Etoposide—germ cell cancer	0.00236	0.00236	CcSEcCtD
Doxylamine—Diarrhoea—Ifosfamide—germ cell cancer	0.00235	0.00235	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00235	0.00235	CcSEcCtD
Doxylamine—Fatigue—Etoposide—germ cell cancer	0.00234	0.00234	CcSEcCtD
Doxylamine—Constipation—Etoposide—germ cell cancer	0.00232	0.00232	CcSEcCtD
Doxylamine—Hepatitis—Methotrexate—germ cell cancer	0.00229	0.00229	CcSEcCtD
Doxylamine—Dizziness—Ifosfamide—germ cell cancer	0.00227	0.00227	CcSEcCtD
Doxylamine—Urinary tract disorder—Methotrexate—germ cell cancer	0.00226	0.00226	CcSEcCtD
Doxylamine—Urethral disorder—Methotrexate—germ cell cancer	0.00224	0.00224	CcSEcCtD
Doxylamine—Feeling abnormal—Etoposide—germ cell cancer	0.00224	0.00224	CcSEcCtD
Doxylamine—Nausea—Dactinomycin—germ cell cancer	0.00223	0.00223	CcSEcCtD
Doxylamine—Vomiting—Ifosfamide—germ cell cancer	0.00219	0.00219	CcSEcCtD
Doxylamine—Hypersensitivity—Cisplatin—germ cell cancer	0.00218	0.00218	CcSEcCtD
Doxylamine—Rash—Ifosfamide—germ cell cancer	0.00217	0.00217	CcSEcCtD
Doxylamine—Dermatitis—Ifosfamide—germ cell cancer	0.00217	0.00217	CcSEcCtD
Doxylamine—Erythema multiforme—Methotrexate—germ cell cancer	0.00217	0.00217	CcSEcCtD
Doxylamine—Urticaria—Etoposide—germ cell cancer	0.00216	0.00216	CcSEcCtD
Doxylamine—Eye disorder—Methotrexate—germ cell cancer	0.00214	0.00214	CcSEcCtD
Doxylamine—Asthenia—Cisplatin—germ cell cancer	0.00213	0.00213	CcSEcCtD
Doxylamine—Cardiac disorder—Methotrexate—germ cell cancer	0.00213	0.00213	CcSEcCtD
Doxylamine—Immune system disorder—Methotrexate—germ cell cancer	0.00207	0.00207	CcSEcCtD
Doxylamine—Mediastinal disorder—Methotrexate—germ cell cancer	0.00206	0.00206	CcSEcCtD
Doxylamine—Nausea—Ifosfamide—germ cell cancer	0.00204	0.00204	CcSEcCtD
Doxylamine—Diarrhoea—Cisplatin—germ cell cancer	0.00203	0.00203	CcSEcCtD
Doxylamine—Hypersensitivity—Etoposide—germ cell cancer	0.002	0.002	CcSEcCtD
Doxylamine—Erythema—Methotrexate—germ cell cancer	0.00199	0.00199	CcSEcCtD
Doxylamine—Asthenia—Etoposide—germ cell cancer	0.00195	0.00195	CcSEcCtD
Doxylamine—Pruritus—Etoposide—germ cell cancer	0.00192	0.00192	CcSEcCtD
Doxylamine—Vomiting—Cisplatin—germ cell cancer	0.00189	0.00189	CcSEcCtD
Doxylamine—Rash—Cisplatin—germ cell cancer	0.00187	0.00187	CcSEcCtD
Doxylamine—Dermatitis—Cisplatin—germ cell cancer	0.00187	0.00187	CcSEcCtD
Doxylamine—Diarrhoea—Etoposide—germ cell cancer	0.00186	0.00186	CcSEcCtD
Doxylamine—Ill-defined disorder—Methotrexate—germ cell cancer	0.00185	0.00185	CcSEcCtD
Doxylamine—Malaise—Methotrexate—germ cell cancer	0.0018	0.0018	CcSEcCtD
Doxylamine—Dizziness—Etoposide—germ cell cancer	0.0018	0.0018	CcSEcCtD
Doxylamine—Vertigo—Methotrexate—germ cell cancer	0.00179	0.00179	CcSEcCtD
Doxylamine—Leukopenia—Methotrexate—germ cell cancer	0.00178	0.00178	CcSEcCtD
Doxylamine—Nausea—Cisplatin—germ cell cancer	0.00176	0.00176	CcSEcCtD
Doxylamine—Convulsion—Methotrexate—germ cell cancer	0.00173	0.00173	CcSEcCtD
Doxylamine—Vomiting—Etoposide—germ cell cancer	0.00173	0.00173	CcSEcCtD
Doxylamine—Rash—Etoposide—germ cell cancer	0.00171	0.00171	CcSEcCtD
Doxylamine—Dermatitis—Etoposide—germ cell cancer	0.00171	0.00171	CcSEcCtD
Doxylamine—Discomfort—Methotrexate—germ cell cancer	0.00168	0.00168	CcSEcCtD
Doxylamine—Confusional state—Methotrexate—germ cell cancer	0.00164	0.00164	CcSEcCtD
Doxylamine—Anaphylactic shock—Methotrexate—germ cell cancer	0.00163	0.00163	CcSEcCtD
Doxylamine—Nausea—Etoposide—germ cell cancer	0.00161	0.00161	CcSEcCtD
Doxylamine—Nervous system disorder—Methotrexate—germ cell cancer	0.0016	0.0016	CcSEcCtD
Doxylamine—Thrombocytopenia—Methotrexate—germ cell cancer	0.00159	0.00159	CcSEcCtD
Doxylamine—Hyperhidrosis—Methotrexate—germ cell cancer	0.00157	0.00157	CcSEcCtD
Doxylamine—Anorexia—Methotrexate—germ cell cancer	0.00155	0.00155	CcSEcCtD
Doxylamine—Hypotension—Methotrexate—germ cell cancer	0.00152	0.00152	CcSEcCtD
Doxylamine—Insomnia—Methotrexate—germ cell cancer	0.00147	0.00147	CcSEcCtD
Doxylamine—Dyspnoea—Methotrexate—germ cell cancer	0.00145	0.00145	CcSEcCtD
Doxylamine—Somnolence—Methotrexate—germ cell cancer	0.00145	0.00145	CcSEcCtD
Doxylamine—Decreased appetite—Methotrexate—germ cell cancer	0.00141	0.00141	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.0014	0.0014	CcSEcCtD
Doxylamine—Fatigue—Methotrexate—germ cell cancer	0.0014	0.0014	CcSEcCtD
Doxylamine—Feeling abnormal—Methotrexate—germ cell cancer	0.00134	0.00134	CcSEcCtD
Doxylamine—Urticaria—Methotrexate—germ cell cancer	0.00129	0.00129	CcSEcCtD
Doxylamine—Hypersensitivity—Methotrexate—germ cell cancer	0.0012	0.0012	CcSEcCtD
Doxylamine—Asthenia—Methotrexate—germ cell cancer	0.00117	0.00117	CcSEcCtD
Doxylamine—Pruritus—Methotrexate—germ cell cancer	0.00115	0.00115	CcSEcCtD
Doxylamine—Diarrhoea—Methotrexate—germ cell cancer	0.00111	0.00111	CcSEcCtD
Doxylamine—Dizziness—Methotrexate—germ cell cancer	0.00108	0.00108	CcSEcCtD
Doxylamine—Vomiting—Methotrexate—germ cell cancer	0.00103	0.00103	CcSEcCtD
Doxylamine—Rash—Methotrexate—germ cell cancer	0.00103	0.00103	CcSEcCtD
Doxylamine—Dermatitis—Methotrexate—germ cell cancer	0.00102	0.00102	CcSEcCtD
Doxylamine—Nausea—Methotrexate—germ cell cancer	0.000966	0.000966	CcSEcCtD
